Close Menu

The Scan

Among the Butterflies

The Guardian reports that DNA barcoding has fueled the discovery of additional species and has pointed to greater biological diversity.

In PLOS this week: interaction of uracil-N-glycosylase and activation induced deaminase enzymes in B cell lymphoma, E. coli strains linked to bloodstream infections, and more.

The Globe and Mail reports UK researchers say their discovery of a new strain of SARS-CoV-2 highlights the importance of viral genomic surveillance.

Nature News reports on which countries got Horizon 2020 research funding.

A Vanilla Genome

Researchers have sequenced the genome of the vanilla plant, which could help boost the quality of vanilla beans, the Miami Herald reports.

In Nucleic Acids Research this week: database of coronavirus gene, pathway, and gene signature data; updates to MethHC database; and more.

Still Likely to Work

The chief executive of BioNTech says the vaccine his company developed with Pfizer should be effective against the new SARS-CoV-2 strain found in the UK, the Guardian reports.

According to Retraction Watch, Nature Communications has retracted a highly criticized article on mentorship.

Just One Coyote

According to ABC7 News, DNA testing indicates one coyote is responsible for three attacks in the East Bay area.

In PNAS this week: effect of mutagenic compounds on transcription in yeast, role for GATA6 in regulating sinus node development, and more.

The US Food and Drug Administration granted an Emergency Use Authorization for Moderna's SARS-CoV-2 vaccine, the New York Times reports.

The European Medicines Agency has recommended the conditional approval of Pfizer and BioNTech's SARS-CoV-2 vaccine, according to the Associated Press. 

Its Implications

Science reports that researchers are working to determine the significance of the SARS-CoV-2 strain identified in the UK.

In PLOS this week: cancer predisposition syndromes among pediatric cancer patients, analysis of Plasmodium vivax population genomics in Panama, and more.

CNBC reports that a US Food and Drug Administration advisory panel voted in favor of authorizing Moderna's SARS-CoV-2 vaccine.

Xavier Becerra, the Health and Human Services Secretary nominee says his main focus, if confirmed, would be the pandemic, the Wall Street Journal reports.

A shipwreck has given researchers a glimpse into the elephants living in West Africa hundreds of years ago, Gizmodo reports.

In Science this week: updated reference genome assembly for the rhesus macaque, and more.

Reuters reports the World Health Organization is to send a team of investigators to Wuhan, China early next year.

According to Retraction Watch, a research technician at Washington State University was caught fabricating gene sequencing data.

And After Death

A small study suggests SARS-CoV-2 lingers after people have died of COVID-19, according to the Washington Post.

In Nature this week: computational tool for the hybrid de novo assembly of human genomes, and more.

Two former political appointees at the US Centers for Disease Control and Prevention describe the sidelining of the agency in the New York Times.

Right at Home

The US Food and Drug Administration has authorized an at-home, over-the-counter test for SARS-CoV-2 from Ellume.

Science reports that individuals with Down syndrome are at increased risk of dying from COVID-19, leading to calls for individuals with Down syndrome to be prioritized for vaccination.


Reuters reports that Germany is seeking to sequence 5 percent of patient samples that test positive for SARS-CoV-2.

23andMe and Medscape say primary care physicians are increasingly more comfortable with discussing direct-to-consumer genetic testing results.

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories.

In Science this week: analysis of genome-wide association studies of chronic kidney disease, and more.